These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10933649)

  • 21. Pharmacokinetics and safety of dirithromycin in the elderly.
    Varanese L
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():169-74. PubMed ID: 8478308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS; Polk RE; Stotka JL
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
    Montero L
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
    Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
    J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.
    McConnell SA; Amsden GW
    Pharmacotherapy; 1999 Apr; 19(4):404-15. PubMed ID: 10212011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species.
    Lassus A
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():115-21. PubMed ID: 2154430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
    Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
    J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
    Kiani R
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):880-4. PubMed ID: 1662638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dirithromycin.
    Med Lett Drugs Ther; 1995 Nov; 37(962):109-10. PubMed ID: 7476670
    [No Abstract]   [Full Text] [Related]  

  • 33. [Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis].
    Sacristán JA; Elviro J; García de Lomas J; Palomino-Nicás J; Sobradillo V; Sánchez Gascón F; Valencia A; Calbo F; Viejo JL; Zamarrón C; Coca E; Casado MA; García Pérez LE; Hernández JM
    Enferm Infecc Microbiol Clin; 1997; 15(7):357-60. PubMed ID: 9410047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dirithromycin, a new antibiotic in the treatment of pharyngeal inflammation].
    Riazantsev SV; Kosenko VA; Vlasova VV; Volkova VV
    Vestn Otorinolaringol; 1995; (5):40-3. PubMed ID: 7502454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue distribution of dirithromycin: comparison with erythromycin.
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities.
    Dryden M; Zhang Y; Wilson D; Iaconis JP; Gonzalez J
    J Antimicrob Chemother; 2016 Dec; 71(12):3575-3584. PubMed ID: 27585969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
    Arbeit RD; Maki D; Tally FP; Campanaro E; Eisenstein BI;
    Clin Infect Dis; 2004 Jun; 38(12):1673-81. PubMed ID: 15227611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.